Pentalpha Engaged on 10 CMBS Transactions in 2017

We represented Pentalpha Surveillance LLC (Pentalpha) in its capacity as operating advisor and/or asset representations reviewer in seven SEC-registered commercial mortgage-backed securities transactions that involved collateral valued in excess of $5.5 billion in the first quarter of 2017, as well as three large-loan 144A deals that involved collateral valued in excess of $1.6 billion. Pentalpha is often retained by CMBS issuers such as Wells Fargo, J.P. Morgan and Goldman Sachs to provide third-party independent oversight of loan securitization trusts’ ongoing operations.

Pentalpha provides a suite of highly specialized products and services to the pace-setters of the international credit markets and structured finance industries. As of May 31, 2017, Pentalpha Surveillance has acted as operating advisor or trust advisor in approximately 105 commercial mortgage-backed securitizations with an aggregate initial unpaid principal balance of approximately $111 billion since October 2010, and as asset representations reviewer in 22 commercial mortgage-backed securitizations with an aggregate initial unpaid principal balance of approximately $21 billion.

You Also May Be Interested In:

  • Representation of Tennessee Community Bank Holdings, Inc., the parent company for Community Bank & Trust located in Ashland City, Tennessee, in its definitive agreement to sell to Reliant Bancorp, Inc. (Nasdaq: RBNC) for $37 million in an approximately 50% stock and 50% cash transaction.

    We represented Tennessee Community Bank Holdings, Inc., the parent company for Community Bank & Trust located in Ashland City, Tennessee,...
    Client Type: Private Company
  • We represented Mid-America Apartments, L.P., the operating partnership of Mid-America Apartment Communities, Inc., in a public offering of $250,000,000 of...
    Client Type: Public Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company